Physician profile
Pablo Jacobo
NPI 1174723621
$6,056.38
in general payments reported to CMS, 2019-2025
8 companies · $50.38 in 2025
The $50.38 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $158 · 2021: $1,759 · 2022: $1,406 · 2023: $2,547 · 2024: $22.66 · 2025: $50.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,060 · Food and Beverage: $781 · Entertainment: $500 · Gift: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,060.16 |
| Food and Beverage | $780.81 |
| Entertainment | $500.00 |
| Gift | $279.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,793.78 | 2019-2023 | |
| Patterson Companies, INC. | $2,102.50 | 2021-2023 | |
| 3m Company | $495.49 | 2021-2023 | Filtek, Scotchbond Universal Plus, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Ultradent Products INC | $279.00 | 2023 | Opalescence |
| Align Technology, INC. | $212.56 | 2020-2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $100.01 | 2019 | |
| Solventum Corporation | $50.38 | 2025 | Filtek |
| Envista Holdings Corporation | $22.66 | 2024 | Tf |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pablo Jacobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.